Treatment of hemophilia B: focus on recombinant factor IX
Massimo Franchini, Francesco Frattini, Silvia Crestani, Cinzia Sissa, Carlo BonfantiDepartment of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, ItalyAbstract: Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX). In...
Guardado en:
Autores principales: | Franchini M, Frattini F, Crestani S, Sissa C, Bonfanti C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1eeeb6d01c54c84a7493cbb6f11530c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Clinical Genetics of Hemophilia B (Factor IX Deficiency)
por: Miller CH
Publicado: (2021) -
Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life
por: Mairead O’Donovan, et al.
Publicado: (2021) -
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A
por: Steven Pipe
Publicado: (2009) -
The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
por: Rivka Yatuv, et al.
Publicado: (2010) -
Recent Advances in the Treatment of Hemophilia: A Review
por: Marchesini E, et al.
Publicado: (2021)